Which medication class is used to treat menorrhagia due to uterine fibroids?

Which medication class is used to treat menorrhagia due to uterine fibroids?

• A. Antifibrinolytics
• B. Hormonal contraceptives
• C. Antibiotics
• D. Nonsteroidal anti-inflammatory drugs (NSAIDs)

Answer: (A)

The correct choice is antifibrinolytics because they work by inhibiting the breakdown of fibrin, which helps to stabilize blood clots, thus effectively reducing excessive menstrual bleeding, or menorrhagia. In cases of menorrhagia caused by uterine fibroids, antifibrinolytic medications can help decrease the severity of bleeding episodes, making them a suitable treatment option. While hormonal contraceptives are often used to manage menorrhagia by regulating menstrual cycles and reducing the heaviness of periods, they are not specifically targeting the fibrinolytic process that antifibrinolytics do. Antibiotics are not relevant in treating menorrhagia related to fibroids unless there is an underlying infection contributing to the bleeding. Nonsteroidal anti-inflammatory drugs (NSAIDs) can help alleviate menstrual pain and reduce blood loss by affecting platelet function and reducing inflammation, but they don’t directly address the clot stabilization aspect like antifibrinolytics do. Thus, antifibrinolytics specifically targeting menorrhagia associated with uterine fibroids make them the most appropriate choice.

The correct choice is antifibrinolytics because they work by inhibiting the breakdown of fibrin, which helps to stabilize blood clots, thus effectively reducing excessive menstrual bleeding, or menorrhagia. In cases of menorrhagia caused by uterine fibroids, antifibrinolytic medications can help decrease the severity of bleeding episodes, making them a suitable treatment option.

While hormonal contraceptives are often used to manage menorrhagia by regulating menstrual cycles and reducing the heaviness of periods, they are not specifically targeting the fibrinolytic process that antifibrinolytics do. Antibiotics are not relevant in treating menorrhagia related to fibroids unless there is an underlying infection contributing to the bleeding. Nonsteroidal anti-inflammatory drugs (NSAIDs) can help alleviate menstrual pain and reduce blood loss by affecting platelet function and reducing inflammation, but they don’t directly address the clot stabilization aspect like antifibrinolytics do. Thus, antifibrinolytics specifically targeting menorrhagia associated with uterine fibroids make them the most appropriate choice.